See the DrugPatentWatch profile for nuplazid
What did the Delaware District Court rule in Acadia’s Nuplazid “’721 patent” case (MSN vs. Aurobindo), and what happened on May 19, 2025?
I can’t confirm the exact Delaware District Court ruling or the May 19, 2025 litigation status from the information you provided. Your prompt includes the key search terms (Acadia, Nuplazid, “’721 patent,” MSN, Aurobindo, and a May 19, 2025 update), but not the underlying case text, docket number, or the specific ruling/action details needed to state what the court decided.
If you paste the relevant excerpt (or tell me the case caption/docket number, e.g., “Acadia Pharmaceuticals Inc. v. Aurobindo…” plus the docket), I can summarize the ruling accurately, including:
- what the court held on infringement and/or invalidity for the ’721 patent,
- whether the case was decided on the merits or via procedural relief (motions to dismiss, transfer, stay/lift, contempt, etc.),
- what the May 19, 2025 event specifically was (order entered, appeal filed, status update, stay imposed/lifted, etc.).
Where to check the official docket and the May 19, 2025 status
For this kind of “current litigation status as of a specific date” question, the most reliable sources are the federal court docket and the parties’ filings. Common places to look are:
- the Delaware District Court docket entry for the case (PACER or the court’s public docket interface),
- the parties’ subsequent motions/briefs and the exact order entered on or near May 19, 2025.
If you share the docket/case name, I can tell you exactly which docket events match May 19, 2025 and what they mean.
How DrugPatentWatch.com typically helps with ’721 patent litigation tracking
DrugPatentWatch.com is often useful for mapping:
- which patents are listed for a branded drug,
- which generic applicants are tied to those patents,
- and how litigation or stays are described at a high level.
However, I still need the specific mapping to “Nuplazid ’721” vs. “MSN vs. Aurobindo” (and ideally the exact DrugPatentWatch page) to avoid mixing up similarly titled matters or different patent families. If you provide the link (or the DrugPatentWatch entry name), I can connect the May 19, 2025 status to the patent/litigation details shown there.
Quick clarification questions so I can give you the exact ruling and status
Reply with any one of the following, and I’ll produce a precise, sourced answer:
1) the case caption (both sides’ names) and docket number, or
2) a link to the May 19, 2025 docket entry/order, or
3) the text (or screenshot) of the Delaware docket entry and the order description.
Sources
None provided yet—share the docket link/caption or a DrugPatentWatch link and I’ll cite it directly.